Difference between revisions of "Mitotane (Lysodren)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(updated content)
Line 1: Line 1:
Also known as o,p′-DDD.
 
 
 
==General information==
 
==General information==
Class/mechanism: Adrenal cytotoxic agent, suppresses adrenal cortex and the extra-adrenal metabolism of cortisol.<ref name="insert">[http://packageinserts.bms.com/pi/pi_lysodren.pdf Mitotane (Lysodren) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/mitotane.pdf Mitotane (Lysodren) package insert (locally hosted backup)]</ref>
+
Class/mechanism: Adrenal cytotoxic agent, suppresses adrenal cortex and the extra-adrenal metabolism of cortisol.<ref name="insert">[http://packageinserts.bms.com/pi/pi_lysodren.pdf Mitotane (Lysodren) package insert]</ref><ref>[[Media:Mitotane.pdf | Mitotane (Lysodren) package insert (locally hosted backup)]]</ref>
 
<br>Route: PO
 
<br>Route: PO
 
<br>Extravasation: n/a
 
<br>Extravasation: n/a
Line 13: Line 11:
 
==Patient drug information==
 
==Patient drug information==
 
*[http://www.uptodate.com/contents/mitotane-patient-drug-information Mitotane (Lysodren) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/mitotane-patient-drug-information Mitotane (Lysodren) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/mitotane-patient-drug-information Mitotane (Lysodren) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/mitotane-patient-drug-information Mitotane (Lysodren) patient drug information (UpToDate)]</ref>
 +
 +
==Also known as==
 +
o,p′-DDD.
  
 
==References==
 
==References==

Revision as of 08:24, 2 March 2015

General information

Class/mechanism: Adrenal cytotoxic agent, suppresses adrenal cortex and the extra-adrenal metabolism of cortisol.[1][2]
Route: PO
Extravasation: n/a

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Diseases for which it is used

Patient drug information

Also known as

o,p′-DDD.

References